About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Better Treatment for Schizophrenia With Novel Drug Target

by Himabindu Venkatakrishnan on December 10, 2014 at 11:29 AM
Font : A-A+

 Better Treatment for Schizophrenia With Novel Drug Target

A novel drug target that could lead to the development of better antipsyhcotic medications has been identified by scientists at the Centre for Addiction and Mental Health.

Dr. Fang Liu, Senior Scientist in CAMH's Campbell Family Mental Health Research Institute and Professor in the Department of Psychiatry, University of Toronto, and her team published their results online in the journal Neuron.

Advertisement

Current treatment for patients with schizophrenia involves taking medications that block or interfere with the action of the neurotransmitter dopamine, which acts on dopamine D2 receptors in the brain. However, because this D2-blocking action may cause unwanted side-effects, such as slow gait, stiffness and tremor, Dr. Liu and her team looked for new ways to interfere with the action of D2 receptors, without causing these side-effects.

Dr. Liu and colleagues showed that the D2 receptor could combine with a protein called the Disrupted-In-Schizophrenia (DISC1) protein. Then, they showed that levels of this combined protein were higher in post-mortem brain tissues of deceased patients with schizophrenia, suggesting it was associated with the illness. Delving even further, the researchers identified the regions where the two proteins bound together.
Advertisement

With this information, they were able to generate a peptide to disrupt the binding of the two proteins, speculating that it may reduce symptoms. In animal models of schizophrenia, they were able to demonstrate that this disruption led to antipsychotic effects, comparable to commonly used antipsychotic medications, but without their side-effects.

"The most exciting aspect of our finding is not the antipsychotic effect of this peptide, which all current antipsychotics have, but rather the possibility of a lack of the side-effects in humans compared to current medications", says Dr. Liu. "We hope that it will lead to a better treatment for schizophrenia patients who experience side-effects from current medications." These side-effects discourage some patients from taking their medications, which impacts recovery.

Schizophrenia is a chronic, often severe and disabling mental illness that affects one percent of the general population.

"Our future steps are to determine how this discovery can be translated into a novel treatment for patients as soon as possible," says Dr. Liu. "We are optimistic that our findings will lead to new and better options for treatment for schizophrenia."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Tea Protects against Blood Pressure and Heart Diseases
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
Cervical Cancer Awareness Month 2022
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Schizophrenia Signature Drug Toxicity Mental Health - Neurosis vs Psychosis Schizoaffective Disorder Mind-wandering Paranoia Anosognosia Antipsychotic Medications 

Recommended Reading
Quiz on Schizophrenia
Schizophrenia is a mental disorder that affects young adults; nearly 7% of the adult population ......
Schizophrenia is a Cluster of Eight Diseases - Significant Breakthrough
Schizophrenia is not a single disease caused by one gene as previously thought, but a group of ......
Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social ......
Antidiabetic GLP-1 Analogs May Benefit Schizophrenia Patients With Antipsychotic-Induced Weight Gain
GLP-1 analogs used to treat diabetes may also help with weight loss in schizophrenia patients with ....
Anosognosia
Anosognosia is the lack of awareness or insight in a patient to understand that he/she has a disease...
Antipsychotic Medications
Antipsychotics are the class of drugs which help in treating mental disorders like schizophrenia, bi...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Mental Health - Neurosis vs Psychosis
Mental well-being is a concern and abnormal coping of emotions can lead to neurosis or psychosis. Me...
Mind-wandering
Mind wandering is a spontaneous and unintentional shifting of attention of thoughts from a primary t...
Paranoia
Paranoia is a false belief where the individual feels unfairly targeted or persecuted by everyone el...
Schizoaffective Disorder
Schizoaffective disorder is a serious mental disorder in which the individual reflects symptoms that...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)